Which ASX shares are ending the week as the biggest movers today?

The ASX 300 has spent the day in the red…
The post Which ASX shares are ending the week as the biggest movers today? appeared first on The Motley Fool Australia. –

The S&P/ASX 300 Index (ASX: XKO) is edging slightly lower today after most company’s wrapped up their earnings season.

During afternoon trade, the ASX 300 is down 0.11% to 7,461 points.

Let’s take a look at which ASX companies are sprinting on the ASX 300 chart today.

Clinuvel Pharmaceuticals Limited (ASX: CUV)

The Clinuvel share price is rocketing 16.28% to a multi-year high of $34 following an optimistic broker note.

Multinational investment bank, Jefferies raised its price target for Clinuvel by 27% to a bullish $36.80. It appears its analysts viewed the company’s full-year results in a positive light.

Based on the current share price, this implies an upside of around 8.2% for investors.

Blackmores Limited (ASX: BKL)

The Blackmores share price is also pushing ahead on Friday, up 6.65% to $98.21. The health supplements company also received a broker note by Macquarie following the release of its full-year results yesterday.

Analysts at Macquarie added 19% to its outlook on Blackmores, valuing its shares at $87.50 apiece. It’s worth noting that this is still a significant downside from the current price, roughly 11%.

Atlas Arteria Group (ASX: ALX)

Another significant mover today is the Atlas Arteria share price, up 6.27% to $6.69. The toll-road developer provided its half-year results yesterday, however, a number of brokers weighed in on the company.

Swiss investment firm, UBS lifted its rating on Atlas Arteria shares by 19% to $6.85. Morgans has a slightly bearish view, adding just 1.7% to $6.44. And lastly, Macquarie improved its assessment by 4.8% to $6.52.

And which ASX companies are heading the other way?

Australian Strategic Materials Ltd (ASX: ASM)

Deep in negative territory, the Australian Strategic Minerals share price is down a sizeable 16.51% to $11.40. Investors are heading for the hills despite no news coming out of the company.

A possible catalyst for the sharp fall could be investors deciding to take profit off the table. The rare earth elements miner’s shares have climbed to incredible highs over the past year, up 400%. In August alone, the company’s share price rose 72% to hit a record high of $14 apiece.

Integral Diagnostics Ltd (ASX: IDX)

Also being weighed down by investors today is the Integral Diagnostics share price, down 12.96% to $4.70. The company released its full-year results today, highlighting a mostly positive performance.

However, with the ongoing impacts of COVID-19, the group could not provide revenue or profit guidance for FY22.

The post Which ASX shares are ending the week as the biggest movers today? appeared first on The Motley Fool Australia.

Should you invest $1,000 in ASX 300 right now?

Before you consider ASX 300, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and ASX 300 wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

Blackmores (ASX:BKL) share price surges 7% to new 52-week high
Why Ardent Leisure, Blackmores, Clinuvel, & Qube shares are surging higher

ASX 200 midday update: Wesfarmers’ $2.3bn capital return, Appen & Pilbara Minerals fall

ASX 200 drops, A2 Milk sinks, Appen plummets

Why Blackmores, Flight Centre, Kuniko, & Qantas shares are soaring today

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Blackmores Limited. The Motley Fool Australia has recommended Integral Diagnostics Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!